Feb 10, 2017

Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2017

DUBLIN - Feb. 10, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its third quarter of fiscal year 2017 on Tuesday, February 21, 2017. A news release...

DUBLIN - Feb. 10, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its third quarter of fiscal year 2017 on Tuesday, February 21, 2017. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2017, which ended on Friday, January 27, 2017.

Medtronic will host a webcast at 7:00 a.m. CST to discuss financial results for its third quarter of fiscal year 2017. The webcast can be accessed at http://investorrelations.medtronic.com on February 21, 2017.

Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.

Looking ahead, Medtronic plans to report its fiscal 2017 fourth quarter financial results on Thursday, May 25, 2017, and for fiscal year 2018, the company plans to report its fiscal first and second quarter financial results on Tuesday, August 22, 2017, and Tuesday, November 21, 2017, respectively. Additional details will be provided closer to the specific quarterly earnings release date.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

 

-end-

 

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626